Ardelyx, Inc. ( ARDX) - Stock Earnings
ARDX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
ARDX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -407000 USD | 125.2 million USD |
| 2026Q1 | -37.6 million USD | 94.5 million USD |
| 2026Q2 | -16.7 million USD | 120.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ARDX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.1 million USD | 124.5 million USD |
| 2024 | -39.1 million USD | 333.6 million USD |
| 2025 | -61.6 million USD | 407.3 million USD |
| 2026 Est. | — | — |
ARDX
Price: $3.12
52 week price:
Earnings Per Share: -0.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8.1 million
Ebitda: -20.5 millionMarket Capitalization: 837.4 million